Trial Profile
A retrospective comparative study to evaluate the efficacy of preoperative treatment with ulipristal acetate in patients undergoing high complexity hysteroscopic myomectomy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2016
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 05 Nov 2016 Primary endpoint (The number of complete resections) has been met.
- 05 Nov 2016 New trial record
- 19 Oct 2016 Results presented at the 72nd Annual Meeting of the American Society for Reproductive Medicine